nuvalore to Attend BioRN Life Biomedical Convention – Founder Elected as BioRN Executive Board Member

Leimen, Germany — nuvalore GmbH will participate in the BioRN Life Biomedical Convention on February 4, 2026, in Heidelberg, one of the Rhine-Neckar region’s flagship life-science events.

Founder and CEO Dr. Anamarija Ćurić will represent nuvalore at the convention and will also attend in her new role as an elected member of the Executive Board of the BioRN Life Science Cluster. The appointment reflects nuvalore’s growing role within the regional life-science ecosystem and its commitment to supporting biomedical innovation.

nuvalore will exhibit at Booth 24 at the Heidelberg Congress Center (HCC), presenting its lifecycle-driven analytical development and characterization capabilities designed with GMP and regulatory expectations in mind. The team will engage with professionals across analytical development, CMC, quality, drug product development, and manufacturing.

“Analytical decisions made early have long-term regulatory and lifecycle consequences,” said Dr. Ćurić. “At nuvalore, we help teams reduce risk by building analytical strategies that are robust, transferable, and designed with GMP expectations in mind from the start. I look forward to connecting with colleagues across the BioRN community to exchange perspectives and challenges.”

Reflecting on her appointment to the BioRN Executive Board, Dr. Ćurić added:

“The Rhine-Neckar region is one of Europe’s most dynamic biotech hubs and has been my professional home for two decades. BioRN plays a critical role in connecting science, founders, and industry, and I’m honored to contribute to strengthening the ecosystem, fostering collaboration, and accelerating the translation of research into patient impact.”

About nuvalore GmbH

nuvalore is a trusted partner delivering end-to-end analytical services that advance drug products across a wide range of therapeutic modalities. Operating in both R&D and GMP environments, we tailor each approach to your needs through development, analytical strategy, and manufacturing support. Using QbD/AQbD principles and ICH Q14-aligned methodologies, we provide robust, regulatory-ready data that accelerate progress, reduce risk, ensure compliance, and safeguard product quality.

To learn more, visit – https://nuvalore.com/

About BioRN Life Biomedical Convention 2026

The BioRN Life Biomedical Convention 2026 will take place on February 4, 2026, at the Heidelberg Congress Center and is expected to welcome up to 500 participants from academia, startups, and industry across the Rhine-Neckar life-science ecosystem.

Further information –  https://biorn.org/news-events/life-the-biomedical-convention-2026/